Patents by Inventor Brad Bond

Brad Bond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240344069
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Application
    Filed: June 25, 2024
    Publication date: October 17, 2024
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser
  • Patent number: 12054713
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: August 6, 2024
    Assignee: Emerald Therapeutics, Inc.
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser
  • Publication number: 20210102207
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Application
    Filed: November 30, 2020
    Publication date: April 8, 2021
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser
  • Patent number: 10883106
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Grant
    Filed: October 25, 2019
    Date of Patent: January 5, 2021
    Assignee: Emerald Therapeutics, Inc.
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser
  • Publication number: 20200056180
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Application
    Filed: October 25, 2019
    Publication date: February 20, 2020
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser
  • Patent number: 10479994
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: November 19, 2019
    Assignee: Emerald Therapeutics, Inc.
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser
  • Publication number: 20170200080
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Application
    Filed: March 27, 2017
    Publication date: July 13, 2017
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser
  • Patent number: 9624495
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Grant
    Filed: May 26, 2015
    Date of Patent: April 18, 2017
    Assignee: Emerald Therapeutics, Inc.
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser
  • Publication number: 20150361426
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Application
    Filed: May 26, 2015
    Publication date: December 17, 2015
    Inventors: Daniel J. KLEINBAUM, Brian M. FREZZA, Brad BOND, Jonathan LEUNG, George W. FRASER
  • Patent number: 9068218
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: June 30, 2015
    Assignee: Emerald Therapeutics, Inc.
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser
  • Publication number: 20140206744
    Abstract: Provided are nucleic acid translators capable of carrying out logic operations with improved efficiency, maximized output and reduced off-target effects, in particular in a biological system. Methods of using these translators to transduce signal are also provided.
    Type: Application
    Filed: March 13, 2013
    Publication date: July 24, 2014
    Applicant: Emerald Therapeutics, Inc.
    Inventors: Daniel J. Kleinbaum, Brian M. Frezza, Brad Bond, Jonathan Leung, George W. Fraser